Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

HOPE-CVD-Virtual: A Virtual Trial to Evaluate the Primary Prevention of CVD — Stella

Home/Cardiovascular Diseases/HOPE-CVD-Virtual: A Virtual Trial to Evaluate the Primary Prevention of CVD

View on ClinicalTrials.gov

Recruiting

Back to Cardiovascular Diseases trials

HOPE-CVD-Virtual: A Virtual Trial to Evaluate the Primary Prevention of CVD

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Singapore

National University of Singapore, Singapore, Singapore

Key details

Sponsor

National University of Singapore

Collaborators

National Medical Research Council (NMRC), Singapore, Nanyang Technological University

Enrollment target

~1,500 participants

Started

May 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

30 Years – 74 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.